Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v8-FR
Language French French
Date Updated 2018-05-08 2018-04-24
Drug Identification Number 02273233 02273233
Brand name CADUET CADUET
Common or Proper name Caduet Caduet
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients AMLODIPINE ATORVASTATIN AMLODIPINE ATORVASTATIN
Strength(s) 5MG 10MG 5MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 90s 90s
ATC code C10BX C10BX
ATC description LIPID MODIFYING AGENTS, COMBINATIONS LIPID MODIFYING AGENTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-04-11 2018-04-11
Estimated end date 2018-05-07
Actual end date 2018-05-07
Shortage status Resolved Actual shortage
Company comments
Health Canada comments